New recommendations issued for pneumococcal vaccine in high-risk adults

Authors concluded that that the benefit of the vaccine in preventing long COVID is due mainly to the fact it mitigates the risk of infection.

Drug Topics sat down with Laird Leavoy, President of American Pharmacies, to discuss the role leadership plays in the independent pharmacy industry.

With pressure from the House GOP, expected PBM reform was not included in Congress’ end-of-year spending package.

Tom Utech, PharmD, CEO of iA, joined Drug Topics to discuss his company’s centralized pharmacy fulfillment solutions.

The lawsuit alleges that the company knowingly violated both the Controlled Substances Act and the False Claims Act.

The patient’s symptoms gradually resolved after discontinuing fezolinetant therapy.